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Activation of the West Nile virus NS3 protease: molecular
dynamics evidence for a conformational selection mechanism
Abstract
The flaviviral nonstructural 3 protease (NS3pro) is essential for virus replication and is therefore a
pharmaceutically relevant target to fight Dengue and West Nile virus (WNV). NS3pro is a
chymotrypsin-like serine protease which requires a polypeptide cofactor (NS2B) for activation. Recent
X-ray crystallography studies have led to the suggestion that the substrate binds to the two-component
NS2B-NS3pro enzyme by an induced-fit mechanism. Here, multiple explicit water molecular dynamics
simulations of the WNV NS2B-NS3pro enzyme show that the active conformation of the NS2B cofactor
(in which its beta-loop is part of the substrate binding site) is stable over a 50-ns time scale even in the
absence of the inhibitor. The partial and reversible opening of the NSB2 beta-loop and its correlated
motion with an adjacent NS3pro loop, both observed in the simulations started from the active
conformation, are likely to facilitate substrate binding and product release. Moreover, in five of eight
simulations without inhibitor (started from two X-ray structures both with improperly formed oxyanion
hole) the Thr132-Gly133 peptide bond flips spontaneously thereby promoting the formation of the
catalytically competent oxyanion hole, which then stays stable until the end of the runs. The simulation
results provide evidence at atomic level of detail that the substrate binds to the NS2B-NS3pro enzyme
by conformational selection, rather than induced-fit mechanism.
 1 
 
 
Activation of the West Nile virus NS3 protease:  
Molecular dynamics evidence for a conformational  
selection mechanism 
 
Dariusz Ekonomiuk and Amedeo Caflisch* 
 
 
Department of Biochemistry, University of Zurich 
Winterthurerstrasse 190, CH-8057 Zurich, Switzerland 
*corresponding author e-mail: caflisch@bioc.uzh.ch 
Abstract 
The flaviviral non-structural 3 protease (NS3pro) is essential for virus replication and is 
therefore a pharmaceutically relevant target to fight Dengue and West Nile virus (WNV). 
NS3pro is a chymotrypsin-like serine protease which requires a polypeptide cofactor 
(NS2B) for activation. Recent X-ray crystallography studies have led to the suggestion that 
the substrate binds to the two-component NS2B-NS3pro enzyme by an induced-fit 
mechanism. Here, multiple explicit water molecular dynamics simulations of the WNV 
NS2B-NS3pro enzyme show that the active conformation of the NS2B cofactor (in which 
its β-loop is part of the substrate binding site) is stable over a 50-ns time scale even in the 
absence of the inhibitor. The partial and reversible opening of the NSB2 β-loop and its 
correlated motion with an adjacent NS3pro loop, both observed in the simulations started 
from the active conformation, are likely to facilitate substrate binding and product release. 
Moreover, in five of eight simulations without inhibitor (started from two X-ray structures 
both with improperly formed oxyanion hole) the Thr132-Gly133 peptide bond flips 
spontaneously thereby promoting the formation of the catalytically competent oxyanion 
hole, which then stays stable until the end of the runs. The simulation results provide 
evidence at atomic level of detail that the substrate binds to the NS2B-NS3pro enzyme by 
conformational selection, rather than induced-fit mechanism. 
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1  Introduction 
There are currently neither vaccines nor safe drugs to fight the pathogenic members of the 
flavivirus family like West Nile virus (WNV) and the closely related Dengue virus, which 
are transmitted by mosquito bites. Despite an estimated 2.5 billion people are potential 
victims of encephalitis and other fatal maladies caused by flaviviruses (cdc, 2007), these 
diseases have received much less attention than other tropical diseases like avian influenza 
probably because mosquitos can fly only much shorter distances than migratory birds, and 
flaviviruses are widespread mainly in poor countries. Recently, the non-structural 3 
protease (NS3pro) has been shown to be responsible for cleavage of the viral polyprotein 
precursor and to play a pivotal role in the replication of flaviviruses (Mukhopadhyay et al., 
2005; Chappell et al., 2006). In fact, site directed mutagenesis focused on the NS3pro 
cleavage sites in the polyprotein precursor abolishes viral infectivity (Chappell et al., 
2006). Therefore, NS3pro is one of the most promising targets for drug development 
against flaviviridae infections. In this context it is important to note that two inhibitors of 
the closely related hepatitis C virus protease are under late-stage clinical development 
(Perni et al., 2006; Tomei et al., 1993; Malcolm et al., 2006; Seiwert et al., 2008). 
The flaviviral NS3pro chain adopts a chymotrypsin-like fold with two six-stranded β-
barrels. The binding pocket is small and very shallow with the catalytic triad (His51-
Asp75-Ser135) located at the cleft between the two β-barrels (Erbel et al., 2006). It has 
been reported that the catalytic activity of NS3pro is significantly increased by the presence 
of a 47-residue region of the non-structural cofactor 2B (NS2B) (Yusof et al., 2000). Two 
X-ray structures of WNV NS2B-NS3pro in complex with inhibitors have been solved: One 
with the substrate-based tetrapeptide benzoyl-norleucine-lysine-arginine-arginine-aldehyde 
(Bz-Nle-Lys-Arg-Arg-H, PDB code 2fp7) (Erbel et al., 2006) and the other with bovine 
pancreatic trypsin inhibitor (BPTI, PDB code 2ijo) (Aleshin et al., 2007). Despite the very 
different size of the two inhibitors, these two X-ray structures show essentially identical 
conformations of the NS2B-NS3pro complex except for the oxyanion hole which is in the 
catalytically competent state only in the complex with BPTI.  
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The coordinates of inhibitor-bound and -free NS3pro (but not NS2B) are closely 
superposable with a root mean square deviation (RMSD) of only 0.8 Å for 148 of 151 C
α
 
atoms (Aleshin et al., 2007). On the other hand, there is a remarkable difference in the 
location of the β2-β3 loop of NS2B. This loop is part of the substrate binding site in both 
inhibitor-bound structures whereas in the inhibitor-free structure (PDB code 2ggv) its tip is 
located at a distance of about 50 Å from the active site and protrudes towards the solvent. 
On the basis of this difference as well as the nonproductive conformation of the oxyanion 
hole in the complex with the tetrapeptide inhibitor, it has been suggested that activation 
obeys an induced-fit mechanism (Aleshin et al., 2007). 
Here, explicit water molecular dynamics (MD) simulations are performed to investigate 
the flexibility and relative stability of the putative initial and final structures of this 
mechanism. Multiple MD runs are started from the inhibitor-free and inhibitor-bound 
conformations for a total simulation time of 0.46 µs. The stability of the catalytically 
competent oxyanion hole structure and of the conformation with the NS2B β2-β3 loop 
making part of the substrate binding site provides evidence that (poly)peptide substrate and 
inhibitors bind by conformational selection rather than induced-fit. Moreover, the partial 
opening of the NS2B β2-β3 loop and its correlated motion with an adjacent loop of NS3pro 
are likely to promote substrate binding and product release as these two loops make up the 
nonprime part of the substrate binding site.  
2  Results 
Table I lists the simulations performed as well as their length and RMSD. The 
conformation of the NS2B cofactor in the X-ray structure with the tetrapeptide-aldehyde 
inhibitor (2fp7) is called active hereafter because the NS2B β2-β3 loop is part of the active 
site and the previously reported deleterious effects of mutations in this loop on the catalytic 
activity (Niyomrattanakit et al., 2004). In the following, the analysis focuses on the runs 
without the inhibitor unless explicitely mentioned. The secondary structure assignment and 
residue numbering of Aleshin et al. are used (Aleshin et al., 2007), i.e., the β2-β3 loop of 
NS2B consists of residues Leu79–Phe85, while the loops E1B-F1, B2B-C2, and E2B-F2 of 
NS3pro consist of residues Tyr68–Cys78, Lys117–Glu122, and Val154–Ile162, 
respectively. 
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Overall stability and flexibility 
The low values of the C
α
 RMSD from the X-ray structure used as starting conformation 
indicate that the overall stability is preserved in all MD runs (Table I and Suppl. Mat. 
Fig. S1). Furthermore, there is a very high correlation between the C
α
 atomic fluctuations 
calculated along the MD simulations and the crystallographic temperature factors (Fig. 1), 
except for the E2B-F2 loop in NS3pro and the β2-β3 loop in NS2B. Note that these 
discrepancies can be explained by the contacts with atoms in neighboring proteins which 
restrict the motion of the aforementioned loops in the crystal (PDB codes 2fp7 and 2ggv) 
but are not present in the MD simulations. The low RMSD values and reasonable 
fluctuations indicate that the force field and simulation protocol are adequate for 
investigating the structural plasticity of the WNV NS2B-NS3pro complex. In recent MD 
simulations with a different force field (Zuo et al., 2009), RMSD values of about 2.5 Å 
were observed in a 10-ns run started from the inactive conformation of the NS2B-NS3pro 
complex of the Dengue virus (PDB code 2FOM). On the other hand, Zuo et al. did not 
carry out MD simulations starting from the active conformation of the complex. Yet, the 
main conclusion of their study that the NS2B cofactor is essential for substrate 
binding (Zuo et al., 2009) is consistent with our results (see below). 
Stability of the NS2B cofactor structure in its active conformation 
The active conformation of the NS2B cofactor is stable over the 50-ns time scale of the 
simulations even in the absence of the inhibitor. Moreover, the β2-β3 loop of NS2B shows 
limited flexibility (Fig. 2, top). In the inhibitor-bound conformation, the tips of the NS2B 
β2-β3 loop and NS3pro E1B-F1 loop are in contact (blue structure in Fig. 2, top). The 
separation of the two tips can be monitored by the distance between the C
α
 atoms of NSB2 
Asp82 and NS3pro Lys73 (C
α
-C
α
 distance of 5.0 Å and 5.4 Å  in the complex with the 
tetrapeptide-aldehyde inhibitor [2fp7] and BPTI [2ijo], respectively). Interestingly, the 
simulations of free (started from the active conformation) and inhibitor-bound NS2B-
NS3pro enzyme show similar distribution of the values of this distance which is slightly 
broader in the runs without inhibitor (Fig. 3). The higher distribution for values below 5 Å 
originates from a closure at about 7.5 ns of the β2-β3 loop of NS2B in the 20-ns run of the 
free enzyme (which yields the peak at about 4.5 Å in the histogram in Fig. 3, bottom). The 
similar flexibility of the NS2B β2-β3 loop in the simulations with and without inhibitor 
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(Fig. 3 and Suppl. Mat. Fig. S2) indicate that the active conformation of NS2B is 
structurally stable.  
Flexibility of the β2-β3 loop of NS2B in the simulations started from the inactive 
conformation 
There is a significantly larger displacement of the β2-β3 loop of NS2B in the simulations 
started from the inactive (Fig. 2, bottom) than the active conformation (Fig. 2, top). The C
α
 
RMSD of residues Leu79-Phe85 is almost always higher than 5 Å in the runs started from 
the inactive conformation (Suppl. Mat. Fig. S2). The opposite, i.e., C
α
 RMSD below 5 Å, 
is observed for the runs from the active conformation. As mentioned above, this loop is 
involved in extensive crystal contacts in the 2ggv structure (inactive) but not in the 2fp7 
structure (active). 
Fluctuations of the NS2B β2-β3 loop and correlated motion of active site loops 
facilitate substrate binding 
Reversible local motion of the β2-β3 loop of NS2B on the 10-ns time scale is observed in 
the MD runs of the free enzyme (Fig. 3, top and Suppl. Mat. Fig. S2). As an example, an 
opening and closing event takes place in the first half of the 80-ns run started from the 
active conformation of NS2B (Fig. 2, top). The 10-ns time scale and amplitude of this 
motion are of similar magnitude as observed for loops of other enzymes in previous 
simulation studies (Levy and Caflisch, 2003; Gorfe and Caflisch, 2005; Friedman and 
Caflisch, 2008) [note the similar time scales and amount of displacement in the NS2B loop 
(Fig. 2, top) and the flap of a human aspartic protease Fig. 5 of Ref. (Gorfe and Caflisch, 
2005)] and experimental investigations (Henzler-Wildman et al., 2008). Since the NS2B 
β2-β3 loop (in its active conformation) is located between the E2B-F2 and B2B-C2 loops 
of NS3pro it is worth to investigate eventual correlated displacements. Covariance matrix 
analysis (see Methods section) of the MD trajectories started from the active conformation 
shows correlated motion between the β2-β3 loop of NS2B and the two loops of NS3pro 
(Fig. 4). The fluctuations of the β2-β3 loop and correlated motion with the NS3pro loops 
are likely to promote substrate binding and release by full formation and partial opening of 
the S2 and S3 pockets. Note that this suggestion goes beyond the available experimental 
evidence because the two X-ray structures of inhibitor-bound WNV NS2B-NS3pro enzyme 
show a perfect overlap in the β2-β3 loop of NS2B despite the different sizes and steric 
requirements of BPTI (2ijo) (Aleshin et al., 2007) and the tetrapeptide-aldehyde inhibitor 
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(2fp7) (Erbel et al., 2006). Furthermore, the partial and reversible opening of the NS2B β2-
β3 loop observed in the MD runs started from the active conformation is a much smaller 
motion than the NS2B displacement postulated by comparing the X-ray structures of the 
free (2ggv) and inhibitor-bound (2fp7, 2ijo) WNV NS2B-NS3pro enzyme. 
Displacement of the E2B-F2 loop of NS3pro from the orientation in the X-ray 
structure of the free enzyme 
In all simulations started from the inactive conformation there is a displacement of the 
E2B-F2 loop of NS3pro towards the B2B-C2 loop (Fig. 2, bottom) where the former 
occludes the cavity that is occupied by the β2-β3 loop of NS2B in the inhibitor bound 
structure. This displacement brings the E2B-F2 loop in the same orientation as in the 
inactive structure of Dengue NS3pro (PDB code 2fom) as shown by the small value of the 
C
α
 RMSD of residues Val154-Ile162 from the inactive structure of Dengue NS3pro 
(Suppl. Mat. Fig. S3). The orientation of the E2B-F2 loop of WNV NS3pro in the inactive 
X-ray structure (2ggv) is kept in place by extensive crystal contacts (Fig. 1) due to a 
symmetric dimer which is most probably a crystallization artifact (Aleshin et al., 2007). 
Evidence for conformational selection in the oxyanion hole (S1') 
As mentioned in the Introduction, of the three crystal structures of WNV NS2B-NS3pro 
only the complex with BPTI (2ijo) has a catalytically competent oxyanion hole with the 
backbone NH groups of residues 133-135 pointing into the hole (green structure in Fig. 5, 
top). On the other hand, both X-ray structures used in the MD simulations (2fp7 and 2ggv) 
show a nonproductive orientation of the NH group of residue 133. The spontaneous 
reorientation of the Thr132-Gly133 peptide bond that result in the formation of the 
catalytically competent oxyanion hole is observed in three (of the four) MD runs started 
from the enzyme structure with the β2-β3 loop of NS2B far away from the active site 
(Fig. 5) as well as in two MD runs initiated from the active conformation of NS2B (not 
shown). The full formation of the oxyanion hole is irreversible in the time scale of the MD 
simulations. Therefore, the simulations without inhibitor indicate that the catalytically 
competent oxyanion hole is structurally stable, which is not consistent with the postulated 
induced-fit mechanism. In other words, this MD result is in net contrast with the suggestion 
that the nonproductive conformation of the hole is favored in the absence of 
substrate (Aleshin et al., 2007), which was based on the differences observed in the X-ray 
structures with the tetrapeptide-aldehyde inhibitor (Erbel et al., 2006) and BPTI (Aleshin 
et al., 2007). 
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Evidence for conformational selection in the S1 pocket 
An aspartate residue (Asp129) is located at the base of the S1 pocket of NS3pro as in most 
trypsin-like serine proteases. Of the three possible rotamers of the χ1 angle of Asp129, only 
the trans (180 degrees) is optimal for salt bridge formation with the P1 Lys or Arg side 
chain in the substrate (as in the X-ray structure of the complex with the tetrapeptide-
aldehyde inhibitor) (Erbel et al., 2006). The -60-degree rotamer of Asp129 results in a less 
favorable orientation for the intermolecular salt bridge than the trans rotamer, whereas the 
+60-degree rotamer results in an orientation of the side chain with the carboxy group far 
away from the base of the S1 pocket. Interestingly, along the MD simulations the χ1 angle 
of Asp129 only sporadically assumes the +60 rotamer. It is mainly in the trans and -60 
rotamer in the simulations started from the active and inactive conformation, respectively, 
but frequent transitions are observed between these two states (Fig. 6). The stability of the 
Asp129 orientation that favors salt bridge formation with the substrate provides further 
evidence that WNV NS3pro binds the substrate by a conformational selection mechanism 
rather than induced fit.  
3  Discussion 
A precise balance between structural plasticity and stability is required for the efficient 
activity of most enzymes. We have performed MD simulations to investigate the flexibility 
and relative stability of the inhibitor-bound and inhibitor-free X-ray structures of the WNV 
NS2B-NS3pro enzyme, which differ significantly in the position and orientation of the β2-
β3 loop of the NS2B cofactor. In the crystal structure of WNV NS2B-NS3pro in the 
complex with a tetrapeptide-aldehyde inhibitor (PDB code 2fp7) the β2-β3 loop is part of 
the active site (and this conformation is referred to as active), while in the X-ray structure 
of the free enzyme (2ggv, termed inactive) its tip is located at a distance of about 50 Å  and 
protrudes towards the solvent though it is stabilized in part by crystal contacts. Three main 
observations emerge from the analysis of the MD trajectories and comparison with the 
available crystal structures. First, the active conformation of the NS2B β2-β3 loop is stable 
on a 50-ns time scale even in the absence of the inhibitor. Furthermore, it is less flexible in 
MD runs started from the active structure than the inactive. These simulation results 
provide strong evidence that the conformation of the NS2B-NS3pro enzyme with the NS2B 
β2-β3 loop as part of the active site is a (meta)stable state. Furthermore, these observations 
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justify the use of the active structure for high-throughput docking, which has resulted in the 
recent discovery of non-peptidic inhibitors (Ekonomiuk et al., 2009). 
Second, the MD simulations started from the active conformation indicate that the 
partial and reversible opening of the NS2B β2-β3 loop and its correlated motion with the 
adjacent NS3pro E2B-F2 loop are involved in substrate binding and product release. Since 
these loops make up the S2-S4 pockets of the NS2B-NS3pro complex the reversible motion 
is likely to facilitate the binding of the non-prime part of the polypeptide substrate to the 
active conformation of the NS2B-NS3pro enzyme. 
Third, the catalytically competent conformation of the S1' and S1 pockets is more stable 
than the nonproductive counterpart. In fact, the spontaneous and irreversible formation of 
the catalytically competent oxyanion hole at the S1' pocket is observed in five of eight MD 
simulations. Furthermore, the Asp129 side chain at the bottom of the S1 pocket switches 
rapidly in-and-out of an orientation that favors binding of a positively charged side chain 
(P1 of substrate), and is observed most of the time in the productive orientation. Therefore, 
the MD simulations indicate that the natural substrate and the known peptide inhibitors of 
the two-component flaviviral enzyme NS2B-NS3pro bind to a (meta)stable conformation 
rather than by inducing a large conformational transition. 
4  Material and Methods 
MD simulations  
The coordinates of the inhibitor-free WNV NS3pro-NS2B protease (Aleshin et al., 2007) 
and its complex with the tetrapeptide inhibitor Bz-Nle-Lys-Arg-Arg-H (Erbel et al., 2006) 
were downloaded from the PDB database (entries 2ggv and 2fp7, respectively). Only the 
complex with the tetrapeptide inhibitor was available (but not the BPTI complex) when this 
study was initiated, which explains why the 2fp7 (and not 2ijo) structure was used for the 
simulations from the active conformation. All termini, including those next to the segment 
missing in the 2fp7 X-ray structure (residues 28-32 of NS3pro), were neutralized by the  
-COCH3 group and the -NHCH3 group at the N-terminus and C-terminus, respectively. To 
reproduce neutral pH conditions the side chains of aspartates and glutamates were 
negatively charged, those of lysines and arginines were positively charged, and histidines 
were considered neutral. The protein was immersed in a orthorhombic box of 
preequilibrated water molecules. The size of the box was chosen to have a minimal 
distance of 13 Å between the boundary and any atom of the protein. The simulation system 
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contained ten (or seven in the peptidic inhibitor complex system) sodium cations to 
compensate for the net negative charge of the NS3pro/NS2B complex. The program 
VMD (Humphrey et al., 1996) was used for setting up the simulation system, while 
minimization, heating and production runs were performed with NAMD2 (Phillips et al., 
2005) using the CHARMM22 force field (MacKerell Jr. et al., 1998) and the TIP3P model 
of water. Periodic boundary conditions were applied and the particle-mesh Ewald 
approach (Essmann et al., 1995) was used for the long-range electrostatics. The van der 
Waals interactions were truncated at a cutoff of 12 Å and a switch function was applied 
starting at 10 Å. The MD simulations were performed at constant temperature (298 K) and 
constant pressure (1 atm) with a time step of 2 fs using the SHAKE algorithm (Ryckaert 
et al., 1977) to fix the length of covalent bonds involving hydrogen atoms. 
Analysis of MD simulations  
The analysis of the trajectories was performed with CHARMM (Brooks et al., 1983), and 
the program WORDOM (Seeber et al., 2007) which is particularly efficient in handling 
large sets of trajectories. Dynamical cross-correlation matrices were calculated using the 
Bio3d package (Grant et al., 2006) within the R environment for statistical computing (R 
Development Core Team, 2008). 
Electronic supplementary material 
Electronic supplementary material consists of three figures with time series of C
α
 RMSD 
of NS2B-NS3pro, β2-β3 loop of NS2B, and E2B-F2 loop of NS3pro. 
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Table 1:   aThe designations active and inactive are used to specify the conformations of 
the NS2B cofactor with its β2-β3 loop close to the active site and far away from it, 
respectively. bDuplicate runs were started using different seeds for the random distribution 
of the initial velocities. cValue of the C
α
 RMSD averaged over the last 10 ns. The C
α
 
atoms of NS3pro were used to calculate the RMSD except for the segment 28-32, which is 
missing in the 2fp7 structure, and the loops B2B-C2 and E2B-F2 which are flexible.  
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Figure Legends 
Fig. 1. Root mean square fluctuations (RMSF) of C
α
 atoms in Å (black lines with  
y-axis on the left) and crystallographic B-factors (green line with y-axis on the right) as 
a function of residue number. The RMSF values are average values over simulation 
intervals of 5 ns (excluding the first 5 ns). Crystal contacts are shown by blue squares for 
residues with one or more heavy atoms closer than 5 Å to heavy atoms of neighboring 
proteins in the crystal. The secondary structure assignment and residue numbering of 
Aleshin et al. are used. Aleshin et al. (2007), i.e., the β2-β3 loop of NS2B consists of 
residues Leu79–Phe85, while the loops E1B-F1, B2B-C2, and E2B-F2 of NS3pro consist 
of residues Tyr68–Cys78, Lys117–Glu122, and Val154–Ile162, respectively. 
Fig. 2. Flexibility of the β2-β3 loop of NS2B in the absence of the inhibitor. Selected 
snapshots (left) and time series of RMSD of C
α
 atoms 79-85 of NS2B (right) are shown for 
the 80-ns runs started from the active (top) and inactive (bottom) conformation. Different 
colors are used for the NS2B chain and the E2B-F2 loop of NS3pro in both individual 
snapshots and the corresponding data points along the time series. Time series of all other 
MD runs are in the Suppl. Mat. Fig. S2. 
Fig. 3. Time series (top) and distribution (bottom) of the NSB2 Asp82 – NS3pro Lys73 
C
α
-C
α
 distance, which is the distance between the tips of the β2-β3 loop of NS2B and the 
E1B-F1 loop of NS3pro. 
Fig. 4. Correlated motion in the NS2B and NS3pro loops adjacent to the active site. To 
evaluate the statistical noise, i.e., sampling robustness, two simulation intervals were 
analyzed: The 15-30 ns (top, left triangular matrix) and 55-70 ns (bottom, right triangular 
matrix) intervals of the 80-ns MD run started from the active conformation without 
inhibitor. They show similar motional correlations, i.e., high symmetry with respect to the 
diagonal, except for some slightly anticorrelated motion present only in the latter interval. 
The color range varies from blue (fully correlated motion) to red (fully anticorrelated) as 
indicated on the color bar on the right. 
Fig. 5. Spontaneous formation of the oxyanion hole during three of the four MD 
simulations started from the inactive conformation. (Top) The structures with yellow (2fp7) 
and green (2ijo) carbon atoms are shown to illustrate the nonproductive and productive 
orientation of the Thr132-Gly133 peptide bond, respectively. (Bottom) The same colors are 
used for the horizontal lines in the time series of the φ angle of Gly133 which reflects the 
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orientation of the NH group whose flip produces the catalytically competent conformation 
of the oxyanion hole. 
Fig. 6. The orientation of the S1 side chain Asp129 favors intermolecular salt bridge 
formation. Note that only the +60-degree rotamer, which is sporadic, does not allow the salt 
bridge between Asp129 and the Arg or Lys side chain at position P1 of the substrate or 
peptidic inhibitor. 
